Drugs / rATG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03593902 | May 2018 → Oct 2019 | systemic sclerosis | Northwestern University | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rATG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03593902 ↗ |
| Action | Deplete | “a protein that kills the immune cells that are thought to be causing your disease” NCT03593902 ↗ |
| Modality | Protein / enzyme biologic | “a protein that kills the immune cells that are thought to be causing your disease” NCT03593902 ↗ |